 |
 |
According to fairly reliable sources, entacapone will be marketed in Europe as COMTESS and in the US as COMTAN. There is only slight chance that FDA approval could come before the middle of next summer. There are n reports of liver damage from entacapone. I have been taking entacapone for several years and, to the best of my knowledge, suffered no ill effects. Will Johnnston A.P.D.A. DelMarVA Chapter Pres. 4049 Oakland School Road Salisbury MD 21804 USA 410-543-0110 ---------- From: Parkinson's Disease Foundation <[log in to unmask]> To: Multiple recipients of list PARKINSN <[log in to unmask]> Subject: Re: Tasmar replacement? Date: Tuesday, December 01, 1998 7:39 AM Entacapone, to my knowledge, is still before the FDA (i.e., not yet approved in the U.S.). robin elliott, pdf